Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Allogene Therapeutics, Inc. ALLO |
BLACKROCK INC BLK |
11,450,079 5.300% |
-6,322,666 (-35.58%) |
Filing History |
| 2025-03-07 10:01 am Sale |
2025-02-28 | 13G | Allogene Therapeutics, Inc. ALLO |
FMR CORP | 10,225,851 4.900% |
-13,546,144 (-56.98%) |
Filing History |
| 2025-02-14 09:02 am Purchase |
2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Lynx1 Capital Management LP | 10,874,723 5.200% |
10,874,723 (New Position) |
Filing History |
| 2025-02-13 4:31 pm Purchase |
2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Arie Belldegrun, M.D. | 12,393,567 5.800% |
2,497,664 (+25.24%) |
Filing History |
| 2025-02-13 4:29 pm Purchase |
2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 10,905,003 5.100% |
940,656 (+9.44%) |
Filing History |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
FMR CORP | 23,771,995 11.300% |
-1,469,504 (-5.82%) |
Filing History |
| 2024-11-12 1:26 pm Unchanged |
2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO |
The Vanguard Group | 8,327,699 3.980% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO |
BLACKROCK INC BLK |
17,772,745 8.500% |
0 (Unchanged) |
Filing History |
| 2024-11-04 10:57 am Sale |
2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO |
The Vanguard Group | 8,327,699 3.980% |
-703,126 (-7.79%) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO |
BLACKROCK INC BLK |
17,772,745 8.500% |
7,770,941 (+77.70%) |
Filing History |
| 2024-02-14 4:36 pm Purchase |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Arie Belldegrun, M.D. | 9,895,903 5.800% |
1,037,042 (+11.71%) |
Filing History |
| 2024-02-14 4:32 pm Purchase |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 9,964,347 5.800% |
1,536,715 (+18.23%) |
Filing History |
| 2024-02-13 4:59 pm Purchase |
2023-12-29 | 13G | Allogene Therapeutics, Inc. ALLO |
The Vanguard Group | 9,030,825 5.370% |
1,765,604 (+24.30%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Allogene Therapeutics, Inc. ALLO |
FMR CORP | 25,241,499 14.999% |
323,544 (+1.30%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
BLACKROCK INC BLK |
10,001,804 5.900% |
1,115,232 (+12.55%) |
Filing History |
| 2024-01-23 10:02 am Sale |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
STATE STREET CORP STT |
2,427,284 1.440% |
-6,739,124 (-73.52%) |
Filing History |
| 2023-10-25 5:29 pm Unchanged |
2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 13.140% |
0 (Unchanged) |
Filing History |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | Allogene Therapeutics, Inc. ALLO |
FMR CORP | 24,917,955 17.085% |
24,917,955 (New Position) |
Filing History |
| 2023-02-13 4:33 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Chang David D | 8,427,632 5.700% |
8,427,632 (New Position) |
Filing History |
| 2023-02-13 4:31 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Arie Belldegrun, M.D. | 8,858,861 6.100% |
1,655,613 (+22.98%) |
Filing History |